CRG – Company Profile

Mezzanine financing company overview

Mezzanine firm logo:

CRG - mezzanine financing company logo

Headquarters location:

United States

Typical mezzanine financing range:

Between $20-200 million

Geographic focus:

United States, Europe, Australasia, and Canada

Industry focus:

Healthcare

Company profile

CRG is an established and successful global healthcare industry pioneer and investor. Since 2003, they have supported healthcare industry innovation by serving the growth capital needs of their business partners across the globe. For their healthcare financing partners, they invest capital using debt and equity structures in a collaborative partnership approach that focuses on minimized dilution and strong value-added support. For their Limited Partners, they target consistent and attractive absolute returns in diverse market conditions that offer attractive current cash yields and strong downside protection.

CRG sees itself as a team of healthcare industry pioneers offering state-of-the-market growth capital solutions. They are an investment management firm taking an innovative approach to healthcare investing that enables their business partners to become successful market leaders.

For over a decade, CRG has built a market reputation as a nimble first mover associated with some of the most dramatic innovations in structured debt and equity investments. These investments have helped numerous healthcare companies achieve success without sacrificing their equity ownership. Today, CRG offers a full suite of structured debt and equity investment solutions that are uniquely tailored to the needs of its business partners.

The demand for affordable growth capital continues to drive healthcare companies with confidence in their future prospects to seek minimally dilutive, long-term credit financing solutions to meet their growth objectives. CRG offers its business partners deep industry insights, timely structured investment solutions, and a trusted collaborative partnership that delivers valuable support beyond money.

CRG has grown into a premier investment firm with approximately $2 billion under management, a global network of healthcare industry specialists, and a world-class investment portfolio that spans across the healthcare ecosystem.

CRG team overview and commitment to healthcare financing market leadership

The CRG investment team leverages more than 175 years of collective and complementary experience across healthcare, private equity, capital markets, and operations to deliver the most innovative structures to meet the capital needs of their financing partners.

Today’s healthcare financing market leaders must demonstrate industry knowledge and insight, technical expertise and world-class proprietary relationships in order to compete among increasing demands for affordable growth capital. CRG is driven to be a world-class investment management firm that offers:

  • Broad and deep healthcare industry insights into macro-trends and how they affect the marketplace;
  • Exceptional networks of next-generation opinion leaders – from proprietary advisory boards to industry advisors and consultants;
  • Extensive knowledge and understanding about the regulatory and reimbursement environment and how to navigate it;
  • Financial acumen to structure flexible ‘state-of-the-market’ financing solutions; and
  • Market-branded, high-quality investment portfolio that enhances market influence and deal flow

Key differentiators of CRG

  • Industry Knowledge and Networks: they utilize a broad and deep network of industry relationships to help identify healthcare trends, source proprietary investment opportunities, conduct due diligence and mitigate risk, and add value post-investment.
  • Proven Financial Acumen and Flexibility: they have a long history of first mover innovation for many of the most significant innovations in healthcare-related credit.
  • Trusted Partners with Strong Value Add: they leverage their investment team and industry relationships to provide strategic, operations and financial advice; make introductions to strategic and equity sponsors; and offer access to industry experts, key opinion leaders, market consultants, regulatory experts and investment bankers.
  • Market Success: they have built a portfolio of recognized healthcare market leaders from whom they gain industry insights and attract high-quality deal flow. Their investment funds have a demonstrated track record of delivering consistent and attractive absolute returns under diverse market conditions using a private credit strategy that offers attractive current cash yields and strong downside protection.

CRG global reach

They increasingly look abroad to new and under-served markets that are experiencing significant healthcare needs and whose governments and economies are supporting strong innovation. They have invested in commercial-stage healthcare companies from around the world, including Europe, Australasia, Canada and the United States.

To support their efforts and build market presence worldwide, they have a global network of industry specialists and consultants to help them identify and assess high-quality investment opportunities across the healthcare ecosystem. They also leverage their existing relationships with prospective borrowers, portfolio companies and world-class venture capitalists for whom they have become a valued and preferred partner to access high-quality, proprietary deal flow.

They seek to be a trusted long-term partner of choice to their portfolio companies and have established a reputation for tailored solutions, patient capital and strong collaboration.

They offer a range of customized structured mezzanine debt and equity investment solutions that focus on minimized equity dilution and strong value-added support.

They seek to offer a competitive growth capital alternative that is less costly and dilutive than traditional equity financing and more flexible and less restrictive than other forms of capital.

They believe that the key to their long-term success lies in their ability to become a trusted, long-term and valued partner to their companies by providing meaningful and measurable resource support that goes well beyond money.

To that end, they have assembled an outstanding finance and operations team, distinguished Strategic Advisory Committee of healthcare industry thought leaders and a global network of prominent industry executives, researchers, marketers and practitioners whom they routinely tap to offer portfolio teams strategic and financial advice; act as advocates on their behalf with potential strategic investors and equity sponsors; and, introduce to industry experts, key opinion leaders, market consultants, regulatory experts and investment bankers, to name a few.

Investment philosophy/criteria

They target investments between $20-200 million in public and private, commercial-stage healthcare companies that are driving next-generation products, technologies and services that address significant and substantial unmet medical needs. They serve the growth capital needs of commercial-stage public and private healthcare companies who are at critical value inflection points and in need of capital to continue to fund growth and innovation.

Their capital enables companies the opportunity to leverage their current cash flows from commercialized products to launch new products, enter new markets, increase sales, finance acquisitions, fund pipeline projects and support long-term strategic R&D objectives. They offer a minimally-dilutive, flexible source of capital at a competitive cost that allows their business partners to retain control of their businesses and operations.

They look for companies that are developing next-generation healthcare products, technologies and services that address significant and substantial unmet medical needs. They have invested in companies representing large markets that target aging populations and obesity in developed economies; enterprises that address healthcare cost reduction; and, tools and diagnostic service companies that advance personalized medicine.

Target market

CRG market represents a $500 billion investment opportunity consisting of approximately 7,000 small and mid-sized healthcare companies with revenues under $300 million. Their target investment size is between $20 million to $200 million.

Target companies

They have partnered with some of the most innovative and successful companies in the healthcare industry. Their focus is on commercial-stage, niche market leaders with talented management teams and strong prospects in sectors that span the entire healthcare ecosystem, including:

  • biopharmaceuticals
  • specialty pharmaceuticals
  • medical devices
  • drug delivery
  • animal health
  • tools and diagnostics
  • healthcare services.

Website links

Company Home Page Link:

Mezzanine Financing Page of The Company:


Access more mezzanine funds data and advanced filtering options

Premium database access